Rare Cancer
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers. (NCT04166006) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2019-12-12 |
| Ontario-wide Cancer TArgeted Nucleic Acid Evaluation (NCT02906943) | University Health Network, Toronto | 2016-08-01 |
| Genomic Investigation of Unusual Responders (NCT03740503) | University Health Network, Toronto | 2013-11-01 |
| Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study (NCT01517945) | Memorial Sloan Kettering Cancer Center | 2012-01-01 |
Track Rare Cancer automatically
Every clearance here is in the API, with alerts when new ones post.